(Q40782873)
Statements
Phase I study of 24-hour continuous intravenous infusion of recombinant human tumor necrosis factor (English)
Steinmetz T
Schaadt M
Gähl R
Schenk V
Diehl V
Pfreundschuh M
1 October 1988
scientific article